Updated Meta-Analysis Assessing Effects of Baduanjin on Cardiopulmonary Functions of Patients with Coronary Heart Disease

Author: Dongsheng Wang1, Jun Xu2
Affiliation:
1 Physical Education Department, Weifang University, Weifang 261061, China.
2 College of Sports and Art, Shandong Sport University, Jinan 250102, China.
Conference/Journal: Evid Based Complement Alternat Med
Date published: 2022 Sep 29
Other: Volume ID: 2022 , Pages: 3913082 , Special Notes: doi: 10.1155/2022/3913082. , Word Count: 261


Background:
Baduanjin is a kind of moderate-intensity aerobic exercise, but its effect on the cardiac rehabilitation (CR) of patients with coronary heart disease (CHD) is controversial. Furthermore, the small sample size of a single study and the inconsistent selection of evaluation indicators among different studies all promote the necessity of conducting a meta-analysis.

Objective:
This meta-analysis aims to explore whether Baduanjin can effectively improve the cardiopulmonary function in patients with CHD and to assess the extrapolation of the results.

Methods:
Both English and Chinese databases were used for literature retrieval. The Cochrane Collaboration tool was used to evaluate the methodological quality of the included literature. A weighted mean difference and a 95% confidence interval were used to assess the effects of Baduanjin on cardiopulmonary function based on multiple CR indicators. Cochran's Q and I 2 tests were used for the heterogeneity test. A funnel plot and an Egger test were used to evaluate publication bias.

Results:
After literature retrieval, a total of 12 literature papers were included in this meta-analysis, but their methodological quality was unsatisfactory. By comparing differences between CHD patients with and without Baduanjin, we found that levels of 6MWT, LVEF, NT-proBNP, VO2, peak VO2, MVV, and VE, AT were significantly improved in the experimental group, but heterogeneity exists among included studies. Results of subgroup analyses were consistent with combined estimates and suggested a significant effect of Baduanjin on LVEF. The Egger test indicated no significant publication bias.

Conclusion:
Baduanjin is beneficial to CR in CHD patients, but multiple region-based high-quality studies are necessary to verify the results.


PMID: 36212963 PMCID: PMC9536900 DOI: 10.1155/2022/3913082

BACK